You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Patent: 10,039,810


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,039,810
Title:Pharmaceutical compositions and methods for fabrication of solid masses comprising anti-interleukin antibodies
Abstract: Embodiments of the invention provide shaped masses comprising one or more drugs such as proteins or polypeptides and methods for forming such shaped masses. One embodiment provides a shaped mass comprising a drug such as a protein or polypeptide having a biological activity in the body of a mammal. The shaped mass is formed by compression of a precursor material comprising the drug wherein an amount of biologically active drug in the mass is a preserved above a minimum level. Drugs which may be incorporated into the shaped mass may include one or more glucose regulating proteins such as insulin, incretins; and immunoglobulins such as TNF-inhibiting antibodies or interleukin neutralizing antibodies. Embodiments of the shaped mass may be incorporated into a tissue penetrating member which is inserted into the intestinal wall allowing for the oral delivery of proteins and peptides which would otherwise be degraded in the intestinal tract.
Inventor(s): Morales; Mercedes (San Francisco, CA), Imran; Mir (Los Altos Hills, CA), Korupolu; Radhika (Fremont, CA), Hashim; Mir (Fremont, CA)
Assignee: InCube Labs, LLC (San Jose, CA)
Application Number:14/714,136
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

Analyzing the Claims and Patent Landscape of United States Patent 10,039,810

Introduction

When evaluating the significance and value of a patent, such as United States Patent 10,039,810, it is crucial to conduct a comprehensive analysis of its claims and the broader patent landscape. This analysis involves several key aspects, including the patent's claims, its validity, the competitive landscape, and the strategic implications for the patent holder and competitors.

Understanding the Patent Claims

To begin, it is essential to delve into the specifics of the patent claims themselves. Patent claims define the scope of the invention and are critical in determining what is protected under the patent.

Claim Construction

The construction of claims is a legal process that involves interpreting the language of the claims to determine their scope. This process, as highlighted in the Federal Circuit's decisions, must consider the entire claim as a whole, including the specification and any special definitions given by the patentee[2][3].

Patent Eligibility

The patent must satisfy the requirements of patent eligibility under Section 101 of the U.S. Patent Act. This involves ensuring that the claimed invention does not fall within one of the exceptions, such as laws of nature, natural phenomena, or abstract ideas. The Mayo/Alice two-step test is often applied to determine this eligibility[3].

Patent Valuation Methods

Understanding the value of a patent is vital for both the patent holder and potential buyers. There are three primary methods for valuing patents: the cost approach, the income approach, and the market approach.

Cost Approach

This method considers the cost incurred to develop the patent. However, since patents cannot be developed retroactively, this value is often what was paid to develop the asset[1].

Income Approach

This approach looks at the future benefits provided by the patent, such as income or savings, and calculates the present value of these benefits over the patent's lifetime[1].

Market Approach

This method involves looking at comparable sales of similar patents. For example, the sale of Novell's 882 patents for $450 million in 2010, or the $4.5 billion paid for Nortel's 6,000 patent documents, provide benchmarks for valuation[1].

Patent Landscape Analysis

A patent landscape analysis provides a broader view of the technological area in which the patent resides. This analysis is crucial for strategic decision-making.

Identifying Competitors

A comprehensive patent landscape analysis helps in identifying key competitors and their patent portfolios. This can reveal areas of high patent saturation and potential gaps in the market[4].

Technological Trends

By analyzing the patent landscape, one can identify trends in technological development and areas where innovation is concentrated. This helps in making long-term decisions about where to focus R&D efforts[4].

Abandoned Technologies

The analysis can also highlight abandoned technologies, which can indicate areas where companies have shifted their focus. For instance, if a company has ceased filing patents in a particular area, it may suggest that the technology is mature or no longer seen as strategic[4].

Strategic Insights

Competitive Positioning

Understanding the competitive landscape allows the patent holder to position their patent strategically. For example, if the patent is in a highly saturated area, it may be more valuable to focus on licensing or enforcement rather than further development[4].

Licensing and Enforcement

A strong patent in a crowded field can be a significant asset for licensing or enforcement. Companies like Apple and Microsoft have paid substantial amounts for patent portfolios to protect their interests and gain a competitive edge[1].

R&D Direction

The patent landscape can guide R&D efforts by highlighting areas with fewer patents, indicating potential for innovation and less competition. This can help companies pivot to newer, more inventive spaces[4].

Case Studies and Examples

Google-Motorola Deal

The Google-Motorola deal, where Google paid $12.5 billion for Motorola Mobility's assets, including 24,500 patents, is a prime example of the strategic value of patents. This deal was primarily about acquiring patents to protect Google's Android ecosystem[1].

Nortel Patent Sale

The sale of Nortel's patents for $4.5 billion to a consortium including Apple, BlackBerry, Ericsson, Microsoft, and Sony demonstrates the high value placed on patent portfolios in competitive markets[1].

Key Takeaways

  • Claim Construction: Understanding the claims of a patent is crucial for determining its scope and validity.
  • Patent Eligibility: Ensuring the patent satisfies Section 101 requirements is essential for its validity.
  • Valuation Methods: The cost, income, and market approaches provide different perspectives on a patent's value.
  • Patent Landscape Analysis: This analysis helps in identifying competitors, technological trends, and strategic opportunities.
  • Strategic Insights: The patent landscape guides R&D direction, competitive positioning, and licensing/enforcement strategies.

FAQs

Q: What are the primary methods for valuing a patent? A: The primary methods are the cost approach, the income approach, and the market approach.

Q: How does the Mayo/Alice test impact patent eligibility? A: The Mayo/Alice test is a two-step process that determines whether a claimed invention falls within one of the exceptions (laws of nature, natural phenomena, or abstract ideas) and if it includes an inventive concept that makes it patentable[3].

Q: What is the purpose of a patent landscape analysis? A: It provides a comprehensive view of the technological area, helping in identifying competitors, trends, and strategic opportunities for R&D and licensing/enforcement[4].

Q: Can you provide an example of a high-value patent portfolio sale? A: The sale of Nortel's 6,000 patent documents for $4.5 billion is a notable example of the high value placed on patent portfolios in competitive markets[1].

Q: How does the patent landscape influence R&D decisions? A: It helps in identifying areas of high patent saturation and potential gaps, guiding companies to pivot to newer, more inventive spaces[4].

Sources

  1. The Value of a Patent - Perpetual Motion Patents
  2. FEDERAL CIRCUIT FINDS PATENT CLAIMS FOR A GRAPHICAL USER INTERFACE INVENTION - NSIP Law
  3. PATENT ELIGIBLE SUBJECT MATTER: REPORT ON VIEWS AND RECOMMENDATIONS - USPTO
  4. Patent Landscape Analysis - Uncovering Strategic Insights - AcclaimIP

More… ↓

⤷  Subscribe

Details for Patent 10,039,810

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Novartis Pharmaceuticals Corporation COSENTYX secukinumab Injection 125504 January 21, 2015 ⤷  Subscribe 2034-05-15
Novartis Pharmaceuticals Corporation COSENTYX secukinumab For Injection 125504 January 21, 2015 ⤷  Subscribe 2034-05-15
Novartis Pharmaceuticals Corporation COSENTYX secukinumab Injection 125504 May 28, 2021 ⤷  Subscribe 2034-05-15
Novartis Pharmaceuticals Corporation COSENTYX secukinumab Injection 125504 May 11, 2023 ⤷  Subscribe 2034-05-15
Eli Lilly And Company TALTZ ixekizumab Injection 125521 March 22, 2016 ⤷  Subscribe 2034-05-15
Octapharma Pharmazeutika Produktionsges.m.b.h. CUTAQUIG immune globulin subcutaneous (human)-hipp Solution 125668 December 12, 2018 ⤷  Subscribe 2034-05-15
Valeant Pharmaceuticals Luxembourg S.à.r.l. SILIQ brodalumab Injection 761032 February 15, 2017 ⤷  Subscribe 2034-05-15
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.